Medicine guide
Certican 0.1 mg
As listed in the register: Certican 0.1 mg, dispergierbare Tabletten
0.1 mg ·
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Everolimusum
- Made by
- Novartis Pharma Schweiz AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Prophylaxe von Organabstossungen
From the official label · 2026-09-30 · Swissmedic
Details
| Made by | Novartis Pharma Schweiz AG |
|---|---|
| Active substance | Everolimusum |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 0.1 mg |
| Classification | L04AA18 · Cancer treatments and immune-system medicines |
| Dispensing (as stated by the register) | Abgabekategorie B |
| Name in the register | Certican 0.1 mg, dispergierbare Tabletten |
| Packs | 60 Tablette(n) |
| Zulassungsnummer | 56239 |
| Dosisstärke | 2 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.
Certican 0.5 mg0.5 mgPrescription only Novartis Pharma Schweiz AG · Everolimusum · L04AA18Certican 0.75 mg0.75 mgPrescription only Novartis Pharma Schweiz AG · Everolimusum · L04AA18Certican 0.25 mg0.25 mgPrescription only Novartis Pharma Schweiz AG · Everolimusum · L04AA18Certican 1 mg1 mgPrescription only Novartis Pharma Schweiz AG · Everolimusum · L04AA18Afinitor 5 mg5 mgPrescription only Novartis Pharma Schweiz AG · Everolimusum · L01XE10Afinitor 10 mg10 mgPrescription only Novartis Pharma Schweiz AG · Everolimusum · L01XE10